The Assessment of Volume Status by BIA and Lung Ultrasound in Septic AKI Patients Undergoing CRRT

Last updated: January 8, 2019
Sponsor: Yonsei University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Renal Failure

Kidney Disease

Kidney Failure

Treatment

N/A

Clinical Study ID

NCT02384525
4-2014-0791
  • Ages 19-80
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Acute kidney injury(AKI) is one of the most common complications that occur up to 35% of critically ill patients. Septic AKI accounts for one third of them. Patients with septic AKI are widely treated with Continuous renal replacement therapy (CRRT). However, previous studies have hardly documented improvement of mortality in septic AKI patients. Otherwise, Fluid overload in septic shock patients who are undergoing CRRT is proven to be a significant predictor for mortality. Recent studies showed efficacy of bioelectrical impedance analysis and lung ultrasound in assessing fluid status of the patients. Thus, hypothesis of the study is that fluid assessment and control of fluid status using BIA and Lung Ultrasound could be related to the outcome of septic AKI patients who undergo CRRT. In this study, the investigators measure the fluid status of the patients by bioelectrical impedance analysis and lung ultrasound for experimental group, while for control group, fluid status would be determined clinically by the physician. Ultrafiltration rate of experimental group is adjusted to be equal to the value of overhydration measured by BIA.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. body temperature < 36 °C or > 38 °C

  2. heart rate > 90 BPM

  3. respiratory rate > 20 or aPaCO2 < 32 mmHg on ABG

  4. White blood cell count < 4,000 cells/mm3 or > 12,000 cells/mm3 or band forms (immaturewhite blood cells) ≥10%

  5. Evidence of infection

  6. WBCs in normally sterile fluid

  7. Perforated viscus

  8. radiologically proven infection

  9. more than Injury stage in AKI according to RIFLE criteria

  10. septic AKI which is not explained by other cause

  11. patients signed a written informed consent.

Exclusion

Exclusion Criteria:

  1. Younger than 19 years old, older than 80 years old

  2. Previously undergoing dialysis treatment due to ESRD

  3. Underlying malignancy, Life expectancy shorter than 3 month

  4. AKI due to other than sepsis

  5. patients with intracardiac device such as Pacemaker, CRT, ICD

Study Design

Total Participants: 218
Study Start date:
January 01, 2017
Estimated Completion Date:
November 30, 2019

Connect with a study center

  • Severance Hospital

    Seoul, 120-752
    Korea, Republic of

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.